Related Experiment Videos
O-methylasparvenone, a nitrogen-free serotonin antagonist
M Bös1, R Canesso, N Inoue-Ohga
1Pharma Division, Preclinical CNS Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Bioorganic & Medicinal Chemistry
|February 12, 1998
Summary
Researchers discovered O-Methylasparvenone and asparvenone from Aspergillus parvulus as novel 5-HT2C antagonists. These compounds are the first nitrogen-free serotonin ligands, with their structure and activity elucidated through synthesis and analysis.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Neuropharmacology
Background:
- Serotonin receptors, particularly 5-HT2C, are crucial drug targets.
- Natural products serve as a source for novel bioactive compounds.
- Identifying new ligands for serotonin receptors is an ongoing area of research.
Purpose of the Study:
- To isolate and identify novel compounds with 5-HT2C receptor activity from microbial sources.
- To characterize the chemical structure and absolute configuration of isolated compounds.
- To develop a synthetic route for the novel compounds and explore structure-activity relationships.
Main Methods:
- Microbial screening of Aspergillus parvulus broth for 5-HT2C ligands.
- Isolation and purification of O-Methylasparvenone (1) and asparvenone (2).
- X-ray crystallographic analysis of a Mosher-ester derivative of compound 1 to determine absolute configuration.
- Development of a synthetic protocol for racemic O-Methylasparvenone (rac-1).
- Synthesis of derivatives of compound 1 for structure-affinity studies.
Main Results:
- O-Methylasparvenone (1) and asparvenone (2) were isolated and identified as 5-HT2C antagonists.
- Compounds 1 and 2 are the first reported nitrogen-free serotonin ligands.
- The absolute configuration of compound 1 was determined as S.
- An efficient synthetic route for rac-1 was established.
- Structure-affinity relationships for derivatives of compound 1 were elucidated.
Conclusions:
- O-Methylasparvenone and asparvenone are novel nitrogen-free 5-HT2C antagonists with potential therapeutic applications.
- The established synthetic methodology allows for the generation of analogs for further pharmacological investigation.
- The structure-affinity relationship provides insights into the molecular requirements for 5-HT2C antagonism.